Published in Nat Rev Nephrol on May 29, 2012
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26
Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation (2004) 3.78
Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol (2007) 1.94
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia (2012) 1.06
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2009) 3.74
The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. Am J Physiol Renal Physiol (2008) 2.12
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem (2005) 2.05
Spatial-temporal studies of membrane dynamics: scanning fluorescence correlation spectroscopy (SFCS). Biophys J (2004) 1.76
Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76
Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes (2005) 1.70
Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes (2006) 1.64
Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem (2002) 1.58
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest (2006) 1.57
Human podocytes perform polarized, caveolae-dependent albumin endocytosis. Am J Physiol Renal Physiol (2014) 1.54
Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Diabetes Care (2007) 1.40
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res (2008) 1.36
Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int (2002) 1.31
Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes (2010) 1.29
Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol (2007) 1.25
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes (2007) 1.25
Characterization of cholesterol crystals in atherosclerotic plaques using stimulated Raman scattering and second-harmonic generation microscopy. Biophys J (2012) 1.25
Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res (2011) 1.19
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int (2005) 1.17
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol (2009) 1.16
Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. Am J Physiol Endocrinol Metab (2004) 1.16
PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI. Am J Physiol Cell Physiol (2009) 1.14
Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J Biol Chem (2013) 1.13
Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice. J Lipid Res (2010) 1.10
Localized irregularities in hemoglobin flow and oxygenation in calf muscle in patients with peripheral vascular disease detected with near-infrared spectrophotometry. J Vasc Surg (2003) 1.09
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res (2013) 1.09
Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist. Mol Pharmacol (2010) 1.08
Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death. PLoS One (2013) 1.07
Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol (2009) 1.07
Nanometer-scale imaging by the modulation tracking method. J Biophotonics (2011) 1.06
Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2. Arterioscler Thromb Vasc Biol (2013) 1.04
Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease. Circ Res (2010) 1.02
Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease. J Am Soc Nephrol (2005) 1.01
Partitioning of NaPi cotransporter in cholesterol-, sphingomyelin-, and glycosphingolipid-enriched membrane domains modulates NaPi protein diffusion, clustering, and activity. J Biol Chem (2004) 1.01
Acute and chronic changes in cholesterol modulate Na-Pi cotransport activity in OK cells. Am J Physiol Renal Physiol (2005) 1.00
Role of PDZK1 protein in apical membrane expression of renal sodium-coupled phosphate transporters. J Biol Chem (2011) 1.00
Kidney aging--inevitable or preventable? Nat Rev Nephrol (2011) 0.99
Diabetic nephropathy -- a multifaceted target of new therapies. Discov Med (2010) 0.98
Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi. Pflugers Arch (2009) 0.97
Interaction of MAP17 with NHERF3/4 induces translocation of the renal Na/Pi IIa transporter to the trans-Golgi. Am J Physiol Renal Physiol (2006) 0.97
Myosin VI is required for maintenance of brush border structure, composition, and membrane trafficking functions in the intestinal epithelial cell. Cytoskeleton (Hoboken) (2012) 0.97
Effect of hypokalemia on renal expression of the ammonia transporter family members, Rh B Glycoprotein and Rh C Glycoprotein, in the rat kidney. Am J Physiol Renal Physiol (2011) 0.96
PERK-eIF2α-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification. J Am Heart Assoc (2013) 0.94
Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes. Diabetes (2012) 0.94
Intestinal phosphate transport. Adv Chronic Kidney Dis (2011) 0.94
Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency. Am J Physiol Renal Physiol (2009) 0.92
Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. Am J Physiol Renal Physiol (2011) 0.92
Activating transcription factor 4 regulates stearate-induced vascular calcification. J Lipid Res (2012) 0.92
Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem (2011) 0.92
NHE3 regulatory factor 1 (NHERF1) modulates intestinal sodium-dependent phosphate transporter (NaPi-2b) expression in apical microvilli. J Biol Chem (2012) 0.92
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice. J Pharmacol Exp Ther (2012) 0.92
PMA- and ANG II-induced PKC regulation of the renal Na+-HCO3- cotransporter (hkNBCe1). Am J Physiol Renal Physiol (2005) 0.90
Differential modulation of the molecular dynamics of the type IIa and IIc sodium phosphate cotransporters by parathyroid hormone. Am J Physiol Cell Physiol (2011) 0.89
Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis (2007) 0.89
Shank2E binds NaP(i) cotransporter at the apical membrane of proximal tubule cells. Am J Physiol Cell Physiol (2005) 0.88
Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. Am J Physiol Renal Physiol (2011) 0.87
Shank2 redistributes with NaPilla during regulated endocytosis. Am J Physiol Cell Physiol (2010) 0.86
Nuclear hormone receptors in diabetic nephropathy. Nat Rev Nephrol (2010) 0.86
Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. J Vasc Surg (2002) 0.84
Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy. Am J Kidney Dis (2004) 0.84
Renal phosphate-transporter regulatory proteins and nephrolithiasis. N Engl J Med (2008) 0.84
Effect of ischemia reperfusion on sodium-dependent phosphate transport in renal brush border membranes. Biochim Biophys Acta (2005) 0.83
Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters. Kidney Int (2011) 0.82
CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy. J Am Soc Nephrol (2013) 0.82
Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol (2009) 0.82
Inorganic phosphate modulates the expression of the NaPi-2a transporter in the trans-Golgi network and the interaction with PIST in the proximal tubule. Biomed Res Int (2013) 0.81
Hypophosphatemia in vitamin D receptor null mice: effect of rescue diet on the developmental changes in renal Na+ -dependent phosphate cotransporters. Pflugers Arch (2010) 0.81
Renal phosphate-wasting disorders. Adv Chronic Kidney Dis (2006) 0.81
Novel NaPi-2c mutations that cause mistargeting of NaPi-2c protein and uncoupling of Na-Pi cotransport cause HHRH. Am J Physiol Renal Physiol (2008) 0.80
Central control of renal sodium-phosphate (NaPi-2) transporters. Am J Physiol Renal Physiol (2003) 0.80
Role of vacuolar ATPase in the trafficking of renal type IIa sodium-phosphate cotransporter. Cell Physiol Biochem (2011) 0.79
Fluorescence correlation spectroscopy and fluorescence lifetime imaging microscopy. Nephron Exp Nephrol (2006) 0.78
Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice. Diabetologia (2013) 0.78
Role of PDZ domain-containing proteins and ERM proteins in regulation of renal function and dysfunction. J Am Soc Nephrol (2003) 0.78
Regulation of the renal sodium-dependent phosphate cotransporter NaPi2 (Npt2) in acute renal failure due to ischemia and reperfusion. Nephron Physiol (2005) 0.78
Recovery of renal tubule phosphate reabsorption despite reduced levels of sodium-phosphate transporter. Eur J Endocrinol (2004) 0.77
Nuclear receptor LXR: a new partner for sodium-dependent phosphate cotransporters. Contrib Nephrol (2013) 0.77
Regulation of NaPi-IIa mRNA and transporter protein in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi). Pflugers Arch (2004) 0.77
Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids. J Asthma (2003) 0.76
Dynamic imaging of the sodium phosphate cotransporters. Adv Chronic Kidney Dis (2011) 0.75
Correction: Spaceflight Activates Lipotoxic Pathways in Mouse Liver. PLoS One (2016) 0.75
Hyperkalemia with concomitant watery diarrhea: an unusual association. Am J Kidney Dis (2003) 0.75
Regulation of renal NaPi-2 expression and tubular phosphate reabsorption by growth hormone in the juvenile rat. Am J Physiol Renal Physiol (2004) 0.75
Lipids and renal cystic disease. Nephrol Dial Transplant (2010) 0.75
AJP-Cell Physiology initiates publication of the Hans H. Ussing Lecture. Am J Physiol Cell Physiol (2010) 0.75
The flux of phosphate: rapid evolution. Adv Chronic Kidney Dis (2011) 0.75